Infarct-induced steroidogenic acute regulatory protein: a survival role in cardiac fibroblasts.

Steroidogenic acute regulatory protein (StAR) is indispensable for steroid hormone synthesis in the adrenal cortex and the gonadal tissues. This study reveals that StAR is also expressed at high levels in nonsteroidogenic cardiac fibroblasts confined to the left ventricle of mouse heart examined 3 days after permanent ligation of the left anterior descending coronary artery. Unlike StAR, CYP11A1 and 3β-hydroxysteroid dehydrogenase proteins were not observed in the postinfarction heart, suggesting an apparent lack of de novo cardiac steroidogenesis. Work with primary cultures of rat heart cells revealed that StAR is induced in fibroblasts responding to proapoptotic treatments with hydrogen peroxide or the kinase inhibitor staurosporine (STS). Such induction of StAR in culture was noted before spontaneous differentiation of the fibroblasts to myofibroblasts. STS induction of StAR in the cardiac fibroblasts conferred a marked resistance to apoptotic cell death. Consistent with that finding, down-regulation of StAR by RNA interference proportionally increased the number of STS-treated apoptotic cells. StAR down-regulation also resulted in a marked increase of BAX activation in the mitochondria, an event known to associate with the onset of apoptosis. Last, STS treatment of HeLa cells showed that apoptotic demise characterized by mitochondrial fission, cytochrome c release, and nuclear fragmentation is arrested in individual HeLa cells overexpressing StAR. Collectively, our in vivo and ex vivo evidence suggests that postinfarction expression of nonsteroidogenic StAR in cardiac fibroblasts has novel antiapoptotic activity, allowing myofibroblast precursor cells to survive the traumatized event, probably to differentiate and function in tissue repair at the infarction site.

[1]  Xiaoxia Qi,et al.  Heart repair by reprogramming non-myocytes with cardiac transcription factors , 2012, Nature.

[2]  B. Hinz,et al.  Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. , 2012, The American journal of pathology.

[3]  F. Jaisser,et al.  Aldosterone, mineralocorticoid receptor, and heart failure , 2012, Molecular and Cellular Endocrinology.

[4]  F. Jaisser,et al.  Targeting the aldosterone pathway in cardiovascular disease , 2012, Fundamental & clinical pharmacology.

[5]  W. Miller,et al.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. , 2011, Endocrine reviews.

[6]  V. Shoshan-Barmatz,et al.  Oligomerization of the Mitochondrial Protein Voltage-Dependent Anion Channel Is Coupled to the Induction of Apoptosis , 2010, Molecular and Cellular Biology.

[7]  V. Vedantham,et al.  Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors , 2010, Cell.

[8]  E. Kardami,et al.  Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: Expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts , 2010, Developmental dynamics : an official publication of the American Association of Anatomists.

[9]  R. Houtkooper,et al.  MTCH2/MIMP is a major facilitator of tBID recruitment to mitochondria , 2010, Nature Cell Biology.

[10]  J. Baudier,et al.  The AAA+ ATPase ATAD3A Controls Mitochondrial Dynamics at the Interface of the Inner and Outer Membranes , 2010, Molecular and Cellular Biology.

[11]  Stephanie L. K. Bowers,et al.  Cardiac Fibroblast: The Renaissance Cell , 2009, Circulation research.

[12]  V. Papadopoulos,et al.  Cholesterol transport in steroid biosynthesis: role of protein-protein interactions and implications in disease states. , 2009, Biochimica et biophysica acta.

[13]  M. Hori,et al.  Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure , 2009, Journal of hypertension.

[14]  J. Prieto,et al.  Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma. , 2008, Cancer research.

[15]  S. Bolkent,et al.  Cholesterol efflux and the effect of combined treatment with niacin and chromium on aorta of hyperlipidemic rat , 2008, Molecular and Cellular Biochemistry.

[16]  W. Miller,et al.  Steroidogenic Activity of StAR Requires Contact with Mitochondrial VDAC1 and Phosphate Carrier Protein , 2008, Journal of Biological Chemistry.

[17]  Z. Granot,et al.  Turnover of mitochondrial steroidogenic acute regulatory (StAR) protein by Lon protease: the unexpected effect of proteasome inhibitors. , 2007, Molecular endocrinology.

[18]  Xueli Yuan,et al.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.

[19]  V. Papadopoulos,et al.  Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. , 2007, Current pharmaceutical design.

[20]  Giulio Gabbiani,et al.  The myofibroblast: one function, multiple origins. , 2007, The American journal of pathology.

[21]  B. Hinz.  Formation and function of the myofibroblast during tissue repair. , 2007, The Journal of investigative dermatology.

[22]  R. Gomer,et al.  Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice , 2006, Proceedings of the National Academy of Sciences.

[23]  Xiaobo Li,et al.  Cholesterol, LDL, and 25-hydroxycholesterol regulate expression of the steroidogenic acute regulatory protein in microvascular endothelial cell line (bEnd.3). , 2006, Biochemical and biophysical research communications.

[24]  N. Tribulova,et al.  Acute, nongenomic effect of thyroid hormones in preventing calcium overload in newborn rat cardiocytes , 2006, Journal of cellular physiology.

[25]  Y. Jo,et al.  Multiple signaling pathways regulating steroidogenesis and steroidogenic acute regulatory protein expression: more complicated than we thought. , 2005, Molecular endocrinology.

[26]  D. Andrews,et al.  Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis , 2005, The EMBO journal.

[27]  P. Hylemon,et al.  Detection of the steroidogenic acute regulatory protein, StAR, in human liver cells. , 2005, Biochimica et biophysica acta.

[28]  D. B. Hales,et al.  Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. , 2004, Endocrine reviews.

[29]  J. Funder.  Cardiac synthesis of aldosterone: going, going, gone...? , 2004, Endocrinology.

[30]  J. Comella,et al.  Bcl-2 Is a Key Factor for Cardiac Fibroblast Resistance to Programmed Cell Death* , 2004, Journal of Biological Chemistry.

[31]  J. Nehmé,et al.  Aldosterone-synthase overexpression in heart: a tool to explore aldosterone’s effects , 2004, Molecular and Cellular Endocrinology.

[32]  C. Murry,et al.  Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. , 2003, The American journal of pathology.

[33]  Naomi Melamed-Book,et al.  Proteolysis of normal and mutated steroidogenic acute regulatory proteins in the mitochondria: the fate of unwanted proteins. , 2003, Molecular endocrinology.

[34]  J. Comella,et al.  Lack of Apaf-1 expression confers resistance to cytochrome c-driven apoptosis in cardiomyocytes , 2003, Cell Death and Differentiation.

[35]  G. Shore,et al.  BCL-2 Selectively Interacts with the BID-induced Open Conformer of BAK, Inhibiting BAK Auto-oligomerization* , 2003, Journal of Biological Chemistry.

[36]  C. Delcayre,et al.  Expression and modulation of steroidogenic acute regulatory protein messenger ribonucleic acid in rat cardiocytes and after myocardial infarction. , 2003, Endocrinology.

[37]  B. Pitt,et al.  Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. , 2003, The New England journal of medicine.

[38]  V. Lingappa,et al.  Rapid regulation of steroidogenesis by mitochondrial protein import , 2002, Nature.

[39]  B. Hinz,et al.  Myofibroblasts and mechano-regulation of connective tissue remodelling , 2002, Nature Reviews Molecular Cell Biology.

[40]  M. Young,et al.  Cardiac steroidogenesis in the normal and failing heart. , 2001, The Journal of clinical endocrinology and metabolism.

[41]  C. Gomez-Sanchez,et al.  Cardiac Steroidogenesis—New Sites of Synthesis, or Much Ado About Nothing? , 2001 .

[42]  S. Matoba,et al.  Important role of energy-dependent mitochondrial pathways in cultured rat cardiac myocyte apoptosis. , 2001, American journal of physiology. Heart and circulatory physiology.

[43]  J. Schaper,et al.  Time course of the apoptotic cascade and effects of caspase inhibitors in adult rat ventricular cardiomyocytes. , 2001, Journal of molecular and cellular cardiology.

[44]  S. Korsmeyer,et al.  Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death , 2001, Science.

[45]  P. White,et al.  Steroidogenic enzyme gene expression in the human heart. , 2000, The Journal of clinical endocrinology and metabolism.

[46]  B. J. Clark,et al.  Angiotensin II and Cyclic Adenosine 3',5'-Monophosphate Induce Human Steroidogenic Acute Regulatory Protein Transcription through a Common Steroidogenic Factor-1 Element1. , 1999, Endocrinology.

[47]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[48]  R. Dietz,et al.  Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. , 1999, Circulation.

[49]  S. Korsmeyer,et al.  Regulated Targeting of BAX to Mitochondria , 1998, The Journal of cell biology.

[50]  A. Weiss,et al.  Effect of truncated forms of the steroidogenic acute regulatory protein on intramitochondrial cholesterol transfer. , 1998, Endocrinology.

[51]  C. Delcayre,et al.  Myocardial Production of Aldosterone and Corticosterone in the Rat , 1998, The Journal of Biological Chemistry.

[52]  K. Tachibana,et al.  Analysis of the steroidogenic acute regulatory protein (StAR) gene in Japanese patients with congenital lipoid adrenal hyperplasia. , 1997, Human molecular genetics.

[53]  I. Friedberg,et al.  Submitochondrial Distribution of Three Key Steroidogenic Proteins (Steroidogenic Acute Regulatory Protein and Cytochrome P450scc and 3β-Hydroxysteroid Dehydrogenase Isomerase Enzymes) upon Stimulation by Intracellular Calcium in Adrenal Glomerulosa Cells* , 1997, The Journal of Biological Chemistry.

[54]  R. Dietz,et al.  Reactive oxygen species induce apoptosis of vascular smooth muscle cell , 1997, FEBS letters.

[55]  D. Stocco,et al.  Steroidogenic acute regulatory protein (StAR) retains activity in the absence of its mitochondrial import sequence: implications for the mechanism of StAR action. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[56]  S. King,et al.  Steroid production after in vitro transcription, translation, and mitochondrial processing of protein products of complementary deoxyribonucleic acid for steroidogenic acute regulatory protein. , 1995, Endocrinology.

[57]  A. Rogol,et al.  Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. , 1995, Science.

[58]  S. King,et al.  The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). , 1994, The Journal of biological chemistry.

[59]  J. Richards,et al.  Tyrosine kinase inhibitor AG18 arrests follicle-stimulating hormone-induced granulosa cell differentiation: use of reverse transcriptase-polymerase chain reaction assay for multiple messenger ribonucleic acids. , 1994, Endocrinology.

[60]  S. Snyder,et al.  Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[61]  M. Pagano,et al.  Purification and characterization of the activated mineralocorticoid receptor from rat myocardium. , 1990, Biochimica et biophysica acta.

[62]  J. Orly,et al.  Microanalysis of hormone responsive ovarian interstitial gland cells in miniature culture. , 1989, Endocrinology.

[63]  L. Pon,et al.  Acute stimulation of corpus luteum cells by gonadotrophin or adenosine 3',5'-monophosphate causes accumulation of a phosphoprotein concurrent with acceleration of steroid synthesis. , 1988, Endocrinology.

[64]  C. Barnett,et al.  Detection of corticosteroid type I binding sites in heart , 1988, Molecular and Cellular Endocrinology.

[65]  A. Strasser,et al.  The BCL-2 protein family: opposing activities that mediate cell death , 2008, Nature Reviews Molecular Cell Biology.

[66]  K. Jacobson,et al.  Cardioprotective effects of adenosine A1 and A 3 receptor activation during hypoxia in isolated rat cardiac myocytes , 2004, Molecular and Cellular Biochemistry.

[67]  J. Funder.  Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance. , 1997, Annual review of medicine.

[68]  S. King,et al.  Spatio-temporal expression patterns of steroidogenic acute regulatory protein (StAR) during follicular development in the rat ovary. , 1998, Endocrinology.